Category: Technology Licenses
Created On: 2022-04-28
Record Count: 13
- Scientific & Technical Instruments
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 27406
IPSCIO Record ID: 1710
Transmyocardial laser revascularization (TMLR) has emerged as a promising therapy for patients with end-stage coronary artery disease not amenable to other forms of therapy. TMLR is a surgical technique typically performed through a left thoracotomy, which uses a laser to bore 15 to 30 transmural channels from the epicardial to the endocardial surfaces through the left ventricular myocardium of the beating heart in an attempt to improve local perfusion to ischemic myocardial territories not being reached by diseased arteries.
IPSCIO Record ID: 233464
The Licensed Products means Lasers, and, Disposables. Laser shall mean any source of amplified, coherent light having a wavelength between 100 and 400 nanometers. Disposable shall mean apparatus comprised, at least in part, or one of more optical fibers, that is or may be coupled to a Laser, as hereinafter defined, to guide the light emitted from that Laser to a treatment location within a human or animal body. Such apparatus shall fall within the definition of Disposable irrespective of whether it is intended for use in more than one procedure.
Transmyocardial laser revascularization (TMR) is a procedure used to treat inoperable heart disease in people with persistent angina that isn't relieved by any other revascularization method.
IPSCIO Record ID: 27347
IPSCIO Record ID: 139831
IPSCIO Record ID: 6931
IPSCIO Record ID: 1098
LICENSED DELIVERY DEVICE shall mean any device that delivers the laser energy to a desired location which infringes one or more of the valid claims of the Licensed Patents.
IPSCIO Record ID: 27403
IPSCIO Record ID: 27092
IPSCIO Record ID: 4829
IPSCIO Record ID: 158782
'Contact Laser(TM) Patents' means the following three U.S. Patent Nos. 4,693,244; 4,592,353; and 4,736,743.
IPSCIO Record ID: 375426
IPSCIO Record ID: 28946
Bioabsorbable cardiac matrix, or BCM, is currently in a placebo-controlled clinical trial designed to support CE mark registration in the European Union.
BCM is a medical device intended to prevent congestive heart failure following a STEMI, which is a type of severe heart attack.
BCM is delivered during a minimally invasive, commonly performed cardiac procedure called a percutaneous coronary intervention procedure. BCM is a formulated sterile solution of sodium alginate and calcium gluconate designed to be administered as a liquid through the coronary artery. When administered following a STEMI, BCM flows into damaged heart muscle where, in the presence of abnormally high extracellular calcium released by the damaged cells, it forms a protective hydrogel meshwork within the wall of the heartâ€™s left ventricle. Based on pre-clinical animal studies, we believe that BCM has the potential to act as a flexible scaffold to provide physical support to the ventricle wall in the early stages of recovery following a STEMI and prevent further structural damage while the heart muscle heals. In addition, in our pre-clinical animal studies, as calcium levels in the damaged area returned to normal, BCM dissolved and was excreted through normal kidney function.